{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:44:23Z","timestamp":1792176263267,"version":"4.4.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ekir.2020.12.038","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T02:58:41Z","timestamp":1610938721000},"page":"986-994","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Early Posttransplant Blood Transfusion and Risk for Worse Graft Outcomes"],"prefix":"10.1016","volume":"6","author":[{"given":"Reem","family":"Daloul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juarez R.","family":"Braga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Diez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April","family":"Logan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Pesavento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2020.12.038_bib1","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1681\/ASN.2016070797","article-title":"Antibody-mediated rejection due to preexisting versus de novo donor-specific antibodies in kidney allograft recipients","volume":"28","author":"Aubert","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.12.038_bib2","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1681\/ASN.2014040326","article-title":"Non-complement-binding de novo donor-specific anti-HLA antibodies and kidney allograft survival","volume":"27","author":"Guidicelli","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.12.038_bib3","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/tri.12533","article-title":"Pretransplant virtual PRA and long-term outcomes of kidney transplant recipients","volume":"28","author":"Huber","year":"2015","journal-title":"Transpl Int"},{"key":"10.1016\/j.ekir.2020.12.038_bib4","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.12.038_bib5","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/TP.0000000000000469","article-title":"Peak panel reactive antibody, cancer, graft, and patient outcomes in kidney transplant recipients","volume":"99","author":"Lim","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2020.12.038_bib6","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2020.12.038_bib7","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1600-6143.2011.03985.x","article-title":"Pretransplant donor-specific HLA class-I and -II antibodies are associated with an increased risk for kidney graft failure","volume":"12","author":"Otten","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2020.12.038_bib8","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1399-0012.2011.01397.x","article-title":"Blood transfusions in kidney transplant candidates are common and associated with adverse outcomes","volume":"25","author":"Ibrahim","year":"2011","journal-title":"Clin Transplant"},{"key":"10.1016\/j.ekir.2020.12.038_bib9","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/01.tp.0000437435.19980.8f","article-title":"Red blood cell transfusions and the risk of allosensitization in patients awaiting primary kidney transplantation","volume":"97","author":"Leffell","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2020.12.038_bib10","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1093\/ndt\/gft362","article-title":"Sensitization from transfusion in patients awaiting primary kidney transplant","volume":"28","author":"Yabu","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2020.12.038_bib11","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/TP.0b013e3182419864","article-title":"Allosensitization rate of male patients awaiting first kidney grafts after leuko-depleted blood transfusion","volume":"93","author":"Balasubramaniam","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2020.12.038_bib12","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/01.ASN.0000115399.80913.B1","article-title":"Leukocyte reduction of red blood cell transfusions does not decrease allosensitization rates in potential kidney transplant candidates","volume":"15","author":"Karpinski","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.12.038_bib13","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1111\/j.1537-2995.2012.03660.x","article-title":"Leukoreduced blood and sensitization of organ transplant candidates","volume":"52","author":"Scornik","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.ekir.2020.12.038_bib14","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1053\/j.ajkd.2013.06.008","article-title":"KDOQI US commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD","volume":"62","author":"Kliger","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2020.12.038_bib15","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1111\/j.1600-6143.2011.03705.x","article-title":"Blood transfusions in organ transplant patients: mechanisms of sensitization and implications for prevention","volume":"11","author":"Scornik","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2020.12.038_bib16","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1111\/ajt.13795","article-title":"Impact of early blood transfusion after kidney transplantation on the incidence of donor-specific anti-HLA antibodies","volume":"16","author":"Ferrandiz","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2020.12.038_bib17","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1097\/TP.0b013e3181a24b96","article-title":"Effects of blood transfusions given after renal transplantation","volume":"87","author":"Scornik","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2020.12.038_bib18","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/petr.12788","article-title":"Post-transplant blood transfusions and pediatric renal allograft outcomes","volume":"20","author":"Verghese","year":"2016","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.ekir.2020.12.038_bib19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.trim.2013.09.008","article-title":"Peri-operative third party red blood cell transfusion in renal transplantation and the risk of antibody-mediated rejection and graft loss","volume":"29","author":"Fidler","year":"2013","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.ekir.2020.12.038_bib20","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1111\/ajt.15233","article-title":"Shared alloimmune responses against blood and transplant donors result in adverse clinical outcomes following blood transfusion post-renal transplantation","volume":"19","author":"Hassan","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2020.12.038_bib21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/tri.13081","article-title":"An unjustified benefit: immortal time bias in the analysis of time-dependent events","volume":"31","author":"Gleiss","year":"2018","journal-title":"Transpl Int"},{"key":"10.1016\/j.ekir.2020.12.038_bib22","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1002\/sim.5705","article-title":"The performance of different propensity score methods for estimating marginal hazard ratios","volume":"32","author":"Austin","year":"2013","journal-title":"Stat Med"},{"key":"10.1016\/j.ekir.2020.12.038_bib23","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1002\/sim.2174","article-title":"Adjusted Kaplan-Meier estimator and log-rank test with inverse probability of treatment weighting for survival data","volume":"24","author":"Xie","year":"2005","journal-title":"Stat Med"},{"key":"10.1016\/j.ekir.2020.12.038_bib24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1586\/17512433.1.3.391","article-title":"Modeling cumulative incidence function for competing risks data","volume":"1","author":"Zhang","year":"2008","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.ekir.2020.12.038_bib25","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.2215\/CJN.13171215","article-title":"Acute rejection rates and graft outcomes according to induction regimen among recipients of kidneys from deceased donors treated with tacrolimus and mycophenolate","volume":"11","author":"Tanriover","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.12.038_bib26","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2215\/CJN.08710814","article-title":"Induction therapies in live donor kidney transplantation on tacrolimus and mycophenolate with or without steroid maintenance","volume":"10","author":"Tanriover","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.12.038_bib27","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1097\/01.TP.0000441089.39840.66","article-title":"Randomized trial of three induction antibodies in kidney transplantation: long-term results","volume":"97","author":"Ciancio","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2020.12.038_bib28","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.transproceed.2013.07.067","article-title":"Alemtuzumab and minimization immunotherapy in kidney transplantation: long-term results of comparison with rabbit anti-thymocyte globulin and standard triple maintenance therapy","volume":"46","author":"Zachariah","year":"2014","journal-title":"Transplant Proc"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024921000073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024921000073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T03:36:49Z","timestamp":1762832209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024921000073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S2468024921000073"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2020.12.038","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early Posttransplant Blood Transfusion and Risk for Worse Graft Outcomes","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2020.12.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}